Literature DB >> 9093256

High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.

A Kaneko, O Kaneko, G Taleo, A Björkman, T Kobayakawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093256     DOI: 10.1016/S0140-6736(05)62696-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

Review 1.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

2.  Genetic polymorphism of CYP2C19 in Maharashtrian population.

Authors:  Yogita Ghodke; Kalpana Joshi; Yashendra Arya; Anjali Radkar; Aditi Chiplunkar; Pooja Shintre; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

Review 3.  Nonhuman primate models in the genomic era: a paradigm shift.

Authors:  Eric J Vallender; Gregory M Miller
Journal:  ILAR J       Date:  2013

Review 4.  CYP2C19 and CYP2D6 genotypes in Pacific peoples.

Authors:  Nuala A Helsby
Journal:  Br J Clin Pharmacol       Date:  2016-08-26       Impact factor: 4.335

5.  Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.

Authors:  Robabeh Ghiyas Tabari; Abdoljalal Marjani; Ogholdondy Agh Ataby; Azad Reza Mansourian; Nader Mansour Samai
Journal:  Oman Med J       Date:  2013-07

6.  Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.

Authors:  D A Fidock; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 7.  Pharmacogenetic tactics and strategies: implications for paediatrics.

Authors:  W W Weber
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 8.  Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Authors:  Zeruesenay Desta; Xiaojiong Zhao; Jae-Gook Shin; David A Flockhart
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Molecular mechanisms of genetic variation and transcriptional regulation of CYP2C19.

Authors:  Nuala Ann Helsby; Kathryn Elisa Burns
Journal:  Front Genet       Date:  2012-10-10       Impact factor: 4.599

10.  A high incidence of polymorphic CYP2C19 variants in archival blood samples from Papua New Guinea.

Authors:  Huai-Ling Hsu; Kathryn J Woad; D Graeme Woodfield; Nuala A Helsby
Journal:  Hum Genomics       Date:  2008-09       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.